A detailed history of Atria Investments LLC transactions in Grifols Sa stock. As of the latest transaction made, Atria Investments LLC holds 33,758 shares of GRFS stock, worth $294,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,758
Previous 38,727 12.83%
Holding current value
$294,032
Previous $343,000 26.82%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

SELL
$6.99 - $9.55 $34,733 - $47,453
-4,969 Reduced 12.83%
33,758 $251,000
Q3 2024

Nov 01, 2024

BUY
$6.28 - $9.38 $243,205 - $363,259
38,727 New
38,727 $343,000
Q1 2022

May 02, 2022

SELL
$10.37 - $12.73 $1.08 Million - $1.32 Million
-103,966 Closed
0 $0
Q4 2021

Feb 04, 2022

BUY
$10.21 - $15.27 $204,679 - $306,117
20,047 Added 23.89%
103,966 $1.17 Million
Q3 2021

Nov 16, 2021

SELL
$14.07 - $17.3 $196,234 - $241,283
-13,947 Reduced 14.25%
83,919 $1.23 Million
Q2 2021

Aug 10, 2021

BUY
$16.62 - $18.94 $215,411 - $245,481
12,961 Added 15.27%
97,866 $1.7 Million
Q1 2021

May 11, 2021

BUY
$15.15 - $19.78 $187,663 - $245,014
12,387 Added 17.08%
84,905 $1.47 Million
Q4 2020

Feb 12, 2021

BUY
$16.86 - $19.67 $1.22 Million - $1.43 Million
72,518 New
72,518 $1.34 Million
Q1 2020

May 15, 2020

SELL
$16.28 - $25.63 $463,898 - $730,326
-28,495 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$19.57 - $23.52 $148,555 - $178,540
7,591 Added 36.31%
28,495 $664,000
Q3 2019

Nov 14, 2019

SELL
$19.85 - $22.76 $2,560 - $2,936
-129 Reduced 0.61%
20,904 $419,000
Q2 2019

Aug 26, 2019

SELL
$17.59 - $21.1 $305,714 - $366,718
-17,380 Reduced 45.25%
21,033 $460,000
Q2 2019

Aug 09, 2019

BUY
$17.59 - $21.1 $318,625 - $382,205
18,114 Added 89.24%
38,413 $1.49 Million
Q1 2019

May 15, 2019

BUY
$18.01 - $20.11 $54,516 - $60,872
3,027 Added 17.53%
20,299 $408,000
Q4 2018

Feb 12, 2019

BUY
$17.44 - $21.53 $45,814 - $56,559
2,627 Added 17.94%
17,272 $317,000
Q3 2018

Oct 09, 2018

BUY
$19.97 - $21.96 $48,327 - $53,143
2,420 Added 19.8%
14,645 $313,000
Q2 2018

Jul 13, 2018

SELL
$20.16 - $24.68 $39,170 - $47,953
-1,943 Reduced 13.71%
12,225 $263,000
Q1 2018

Apr 30, 2018

BUY
$20.31 - $24.95 $32,922 - $40,443
1,621 Added 12.92%
14,168 $300,000
Q4 2017

Jan 16, 2018

BUY
$20.99 - $23.89 $21,493 - $24,463
1,024 Added 8.89%
12,547 $288,000
Q3 2017

Oct 12, 2017

BUY
$20.07 - $21.89 $231,266 - $252,238
11,523
11,523 $252,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.91B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.